# FDA recall D-0065-2025

> **Unexo Life Sciences Private Limited** · Class II · drug recall initiated 2024-10-24.

## Product

THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5) and b) 6 patches (NDC 71101-001-06, UPC 8 45717 01056 6), Manufactured for: Veridian Healthcare, LLC, Gurnee, IL 60031

## Reason for recall

cGMP Deviations

## Distribution

Nationwide in the US

## Key facts

- **Recall number:** D-0065-2025
- **Recalling firm:** Unexo Life Sciences Private Limited
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2024-10-24
- **Report date:** 2024-12-04
- **Termination date:** 2025-09-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New Delhi, India

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0065-2025

## Citation

> AI Analytics. FDA recall D-0065-2025. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-0065-2025. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*